Harte-Hanks (NASDAQ: HHS) reported Q2 EPS of $0.08, $0.12 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $47.76 million versus the consensus estimate of $48.98 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.